Crow Point Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,706
Closed -$62K 309
2016
Q4
$62K Sell
1,706
-1,940
-53% -$70.5K 0.01% 187
2016
Q3
$169K Buy
+3,646
New +$169K 0.03% 169
2015
Q3
$399K Sell
7,388
-1,942
-21% -$105K 0.06% 126
2015
Q2
$504K Buy
9,330
+630
+7% +$34K 0.07% 115
2015
Q1
$470K Buy
+8,700
New +$470K 0.06% 123
2014
Q3
$391K Buy
7,230
+1,100
+18% +$59.5K 0.05% 149
2014
Q2
$324K Hold
6,130
0.04% 148
2014
Q1
$324K Buy
+6,130
New +$324K 0.04% 148